+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Contraceptive Market by Product (Devices, Drugs), Gender (Female Contraceptive, Male Contraceptive), Method, Distribution - Forecast 2024-2030- Product Image
Global Contraceptive Market by Product (Devices, Drugs), Gender (Female Contraceptive, Male Contraceptive), Method, Distribution - Forecast 2024-2030- Product Image
Sale

Global Contraceptive Market by Product (Devices, Drugs), Gender (Female Contraceptive, Male Contraceptive), Method, Distribution - Forecast 2024-2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4829811
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Contraceptive Market size was estimated at USD 48.43 billion in 2023, USD 54.87 billion in 2024, and is expected to grow at a CAGR of 13.82% to reach USD 119.89 billion by 2030.

Contraceptives, also known as birth control, are methods or devices used to prevent pregnancy. These products or practices can work in various ways, such as inhibiting the fertilization of an egg, preventing the implantation of a fertilized egg in the uterus, or regulating hormonal cycles. The availability and choice of contraception provide individuals with the ability to plan if and when they want to have children, contributing to better health outcomes for women and families. Increased educational campaigns and government initiatives to raise awareness about sexual health and contraceptives have increased the adoption of various contraceptive methods.

Further, enhanced access to healthcare services and family planning in emerging economies has increased the use of contraceptives. Innovations in contraceptive methods leading to more efficient and user-friendly options also bolstered the market growth. However, strict regulatory frameworks can delay product approvals and launches. Resistance in certain regions due to traditional beliefs and religious constraints may pose challenges for the market. Nevertheless, investigating biodegradable and eco-friendly contraceptive products to cater to environmentally conscious consumers is expected to provide an opportunistic way for market growth. Moreover, developments in male contraception methods may bolster the market growth shortly.

Regional Insights

The contraceptive market in the Americas presents a mature landscape with high awareness levels and a strong presence of major pharmaceutical companies. The region is characterized by a wide range of contraceptive methods including birth control pills, IUDs, implants, and condoms. Government policies and non-profit organizations in the United States and Canada play a crucial role in providing accessible contraception, particularly to younger and lower-income populations. The Latin American market is experiencing growth, propelled by public health initiatives aimed at reducing teenage pregnancies and increasing the availability of contraceptives. The EMEA region presents a varying landscape for contraceptives.

Europe has a well-established market with high contraceptive prevalence rates, backed by governmental healthcare systems that offer various contraceptive methods at low or no cost. There is a strong tendency toward long-acting reversible contraceptives (LARCs) such as IUDs. The Middle East, contrastingly, has cultural and religious factors that influence contraceptive use, with varying degrees of accessibility and societal acceptance across different countries. The African continent shows the lowest contraceptive prevalence rate and is experiencing a rise in need for family planning services, driven by international aid, and increasing government focus on women's health issues. The Asia-Pacific region showcases a diverse contraceptive market, heavily influenced by cultural, social, and regulatory factors. The presence of high-population countries coupled with government initiatives and awareness campaigns for the use of contraceptives has propelled the market growth in the region.

Market Trends by Segment

  • Product: High inclination toward contraceptive drugs due to their ease of use and non-invasiveness
  • Gender: Significant adoption of female contraceptives due to availability of a wide range of products
  • Method: Rising preference for barrier methods of contraception that provide a physical and chemical barrier during sexual activities
  • Distribution Channel: Enhanced product distribution through online pharmacies due to their 24/7 services

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Richmond Biotech Company to buy Contraceptive biz for USD 100 Million

Aditxt has announced its intent to acquire Evofem Biosciences, a contraceptive business located in California, for a total purchase price of USD 100 million. The agreement, which has received unanimous approval from the boards of both companies, is slated for completion in the initial half of this year. Evofem Biosciences is known for its innovative product, Phexxi, a non-hormonal contraceptive gel, and the acquisition is expected to incorporate Evofem as a wholly owned subsidiary of Aditxt, further solidifying Aditxt's position in the healthcare market while broadening its product offerings.

UK Launches First Trial of Hormone-free Male Birth Control pill

UK-based Quotient Sciences has initiated the initial trials for YCT-529, an innovative non-hormonal male contraceptive pill. This landmark study, involving 16 participants, is expected to redefine birth control by offering men a hormone-free option. As the goal of gender-inclusive contraceptive methods intensifies, YCT-529 signifies a progressive stride toward balancing the responsibilities of family planning. Quotient Sciences' commitment to this novel approach could not only transform the marketplace for contraceptives but also catalyze a shift in societal norms surrounding reproductive health.

Aditxt Acquires Phexxi Contraceptive Gel-Maker Evofem for USD 100 million

US-based biotech firm Aditxt has announced the acquisition of Evofem Biosciences in a strategic deal valued at approximately USD 100 million. This acquisition represents a significant step for Aditxt, marking its entrance into the sexual and reproductive health sector. This move is anticipated to broaden Aditxt's product range and reinforce its position in the market by catering to the diverse needs of consumers seeking non-hormonal contraceptive methods.

Key Company Profiles

The report delves into recent significant developments in the Contraceptive Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Acme Generics Pvt. Ltd., Afaxys, Inc., Agile Therapeutics, Inc., Amneal Pharmaceuticals LLC, ASKA Pharmaceutical Co., Ltd., Aurobindo Pharma Limited, Bayer AG, Church & Dwight Co., Inc., HLL Lifecare Limited, Insud Pharma, S.L., Johnson & Johnson Services, Inc., Lupin Limited, Mayne Pharma Group Limited, Merck & Co., Inc., Mithra Pharmaceuticals S.A., Okamoto Industries, Inc., Organon & Co., Perrigo Company plc, Pfizer Inc., Piramal Pharma Ltd., Reckitt Benckiser Group plc, RITEX GMBH, Sanofi S.A., Say It With A Condom, LLC., Syzygy Healthcare Solutions LLC, Teva Pharmaceutical Industries Ltd., TherapeuticsMD, Inc., TTK Healthcare Limited, Veru Inc., and Viatris Inc.

This research report offers invaluable insights into various crucial aspects of the Contraceptive Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased awareness regarding sexual health and family planning
5.1.1.2. Supportive government initiatives to encourage use and provision of contraceptive pills
5.1.2. Restraints
5.1.2.1. Adverse health impacts of contraceptive products
5.1.3. Opportunities
5.1.3.1. Introduction of affordable contraceptive methods with extensive R&D
5.1.3.2. Availability of contraceptives through online distribution channels
5.1.4. Challenges
5.1.4.1. Social concerns regarding contraceptive usage and issues with product marketing
5.2. Market Segmentation Analysis
5.2.1. Product: High inclination toward contraceptive drugs due to their ease of use and non-invasiveness
5.2.2. Gender: Significant adoption of female contraceptives due to availability of a wide range of products
5.2.3. Method: Rising preference for barrier methods of contraception that provide a physical and chemical barrier during sexual activities
5.2.4. Distribution Channel: Enhanced product distribution through online pharmacies due to their 24/7 services
5.3. Market Trend Analysis
5.3.1. Significant advancements in contraceptive methods coupled with increasing government and non-government initiatives to promote contraceptives across the Americas
5.3.2. Strong government support to spread awareness of contraceptives and extensive R&D activities to expand product profiles in APAC
5.3.3. Increasing government initiatives promoting family planning and sexual health education, with ongoing advancements in contraceptive methods across EMEA
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Contraceptive Market, by Product
6.1. Introduction
6.2. Devices
6.3. Drugs
7. Contraceptive Market, by Gender
7.1. Introduction
7.2. Female Contraceptive
7.3. Male Contraceptive
8. Contraceptive Market, by Method
8.1. Introduction
8.2. Barrier
8.3. Harmonal
9. Contraceptive Market, by Distribution
9.1. Introduction
9.2. Chain Pharmacy
9.3. Clinics
9.4. Government Network
9.5. Hospital Pharmacy
9.6. Independent Pharmacy
9.7. Online Platform
10. Americas Contraceptive Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Contraceptive Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Contraceptive Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Richmond Biotech Company to buy Contraceptive biz for USD 100 Million
13.3.2. UK Launches First Trial of Hormone-free Male Birth Control pill
13.3.3. Aditxt Acquires Phexxi Contraceptive Gel-Maker Evofem for USD 100 million
13.3.4. Daré Bioscience Launches Phase III Hormone-free Contraceptive Trial
13.3.5. Lupin Launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP in the United States
13.3.6. Bayer and CrossBay Medical to Develop Novel Intrauterine System Inserter
13.3.7. Xiromed LLC Announces Launch of EnilloRing in the United States
13.3.8. Bayer Invests in USD 267.2 Million new Production Facility in Finland to Accelerate Global Access to Modern Contraception
13.3.9. NIH Center Grant Bolsters Male Contraceptive Research
13.3.10. Gates Foundation, Children’s Investment Fund Foundation, Pfizer and BD Company Expand Partnership for Greater Access to Injectable Contraceptive for Women
13.3.11. Perrigo Announces U.S. FDA Approval for Opill OTC Daily Oral Contraceptive
13.3.12. FDA Approves First Nonprescription Daily Oral Contraceptive
13.3.13. Sirona Acquires India’s First Vegan Condom Brand Bleu
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. CONTRACEPTIVE MARKET RESEARCH PROCESS
FIGURE 2. CONTRACEPTIVE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CONTRACEPTIVE MARKET DYNAMICS
FIGURE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CONDOMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CONDOMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGM, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGM, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COPPER IUDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COPPER IUDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HORMONAL IUDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HORMONAL IUDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SUBDERMAL IMPLANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SUBDERMAL IMPLANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INJECTABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVE PILLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVE PILLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL CONTRACEPTIVE PATCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL CONTRACEPTIVE PATCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL CONTRACEPTIVE MARKET SIZE, BY BARRIER, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL CONTRACEPTIVE MARKET SIZE, BY BARRIER, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HARMONAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HARMONAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GOVERNMENT NETWORK, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GOVERNMENT NETWORK, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 85. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 86. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 87. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 88. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 89. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 90. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 91. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 92. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 93. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 94. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 95. BRAZIL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. BRAZIL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 99. BRAZIL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 100. BRAZIL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 101. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 102. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 103. BRAZIL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 104. BRAZIL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 105. BRAZIL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 106. BRAZIL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 107. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 108. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 109. CANADA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 110. CANADA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 111. CANADA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 112. CANADA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 113. CANADA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 114. CANADA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 115. CANADA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 116. CANADA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 117. CANADA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 118. CANADA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 119. CANADA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 120. CANADA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 121. CANADA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 122. CANADA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 123. MEXICO CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 124. MEXICO CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 125. MEXICO CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 126. MEXICO CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 127. MEXICO CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 128. MEXICO CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 129. MEXICO CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 130. MEXICO CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 131. MEXICO CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 132. MEXICO CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 133. MEXICO CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 134. MEXICO CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 135. MEXICO CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 136. MEXICO CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 137. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 138. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 139. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 140. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 141. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 142. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 143. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 144. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 145. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 146. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 147. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 148. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 149. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 150. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 151. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 152. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 154. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 156. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 158. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 160. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 162. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 164. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 166. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 168. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 169. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 170. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 171. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 172. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 173. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 174. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 175. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 176. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 177. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 178. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 179. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 180. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 181. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 182. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 183. CHINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 184. CHINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 185. CHINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 186. CHINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 187. CHINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 188. CHINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 189. CHINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 190. CHINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 191. CHINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 192. CHINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 193. CHINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 194. CHINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 195. CHINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 196. CHINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 197. INDIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 198. INDIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 199. INDIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 200. INDIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 201. INDIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 202. INDIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 203. INDIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 204. INDIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 205. INDIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 206. INDIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 207. INDIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 208. INDIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 209. INDIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 210. INDIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 211. INDONESIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. INDONESIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 214. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 215. INDONESIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 216. INDONESIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 217. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 218. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 219. INDONESIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 220. INDONESIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 221. INDONESIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 222. INDONESIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 223. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 224. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 225. JAPAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 226. JAPAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 227. JAPAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 228. JAPAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 229. JAPAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 230. JAPAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 231. JAPAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 232. JAPAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 233. JAPAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 234. JAPAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 235. JAPAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 236. JAPAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 237. JAPAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 238. JAPAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 239. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 240. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 241. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 242. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 243. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 244. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 245. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 246. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 247. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 248. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 249. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 250. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 251. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 252. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 253. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 256. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 257. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 258. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 259. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 260. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 261. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 262. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 263. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 264. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 265. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 266. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 267. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 268. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 269. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 270. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 271. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 272. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 273. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 274. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 275. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 276. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 277. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 278. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 279. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 280. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 281. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 282. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 283. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 284. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 285. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 286. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 287. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 288. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 289. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 290. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 291. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 292. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 293. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 294. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 295. TAIWAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 296. TAIWAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 297. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 298. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 299. TAIWAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 300. TAIWAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 301. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 302. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 303. TAIWAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 304. TAIWAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 305. TAIWAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 306. TAIWAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 307. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 308. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 309. THAILAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 310. THAILAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 311. THAILAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 312. THAILAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 313. THAILAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 314. THAILAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 315. THAILAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 316. THAILAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 317. THAILAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 318. THAILAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 319. THAILAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 320. THAILAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 321. THAILAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 322. THAILAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 323. VIETNAM CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 324. VIETNAM CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 325. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 326. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 327. VIETNAM CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 328. VIETNAM CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 329. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 330. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 331. VIETNAM CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 332. VIETNAM CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 333. VIETNAM CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 334. VIETNAM CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 335. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 336. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 347. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 348. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 349. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 350. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 351. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 352. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 353. DENMARK CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 354. DENMARK CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 355. DENMARK CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 356. DENMARK CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 357. DENMARK CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 358. DENMARK CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 359. DENMARK CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 360. DENMARK CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 361. DENMARK CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 362. DENMARK CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 363. DENMARK CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 364. DENMARK CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 365. DENMARK CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 366. DENMARK CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 367. EGYPT CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 368. EGYPT CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 369. EGYPT CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 370. EGYPT CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 371. EGYPT CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 372. EGYPT CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 373. EGYPT CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 374. EGYPT CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 375. EGYPT CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2023 (USD MILLION)
TABLE 376. EGYPT CONTRACEPTIVE MARKET SIZE, BY GENDER, 2024-2030 (USD MILLION)
TABLE 377. EGYPT CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 378. EGYPT CONTRACEPTIVE MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 379. EGYPT CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 380. EGYPT CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 381. FINLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 382. FINLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 383. FINLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2023 (USD MILLION)
TABLE 384. FINLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2024-2030 (USD MILLION)
TABLE 385. FINLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2023 (USD MILLION)
TABLE 386. FINLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2024-2030 (USD MILLION)
TABLE 387. FINLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)

Companies Mentioned

  • Abbvie Inc.
  • Acme Generics Pvt. Ltd.
  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Amneal Pharmaceuticals LLC
  • ASKA Pharmaceutical Co., Ltd.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Church & Dwight Co., Inc.
  • HLL Lifecare Limited
  • Insud Pharma, S.L.
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals S.A.
  • Okamoto Industries, Inc.
  • Organon & Co.
  • Perrigo Company plc
  • Pfizer Inc.
  • Piramal Pharma Ltd.
  • Reckitt Benckiser Group plc
  • RITEX GMBH
  • Sanofi S.A.
  • Say It With A Condom, LLC.
  • Syzygy Healthcare Solutions LLC
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD, Inc.
  • TTK Healthcare Limited
  • Veru Inc.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 54.87 Billion
Forecasted Market Value ( USD ) by 2030 $ 119.89 Billion
Compound Annual Growth Rate13.8%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Global Contraceptive Market Analysis & Forecast to 2023-2033: Market By Product; By Gender; By Distribution Channel; and By Region - Product Image

Global Contraceptive Market Analysis & Forecast to 2023-2033: Market By Product; By Gender; By Distribution Channel; and By Region

  • Report
  • 145 Pages
  • Global
From
Global Female Contraceptive Market by Contraceptive Drug (Contraceptive Injections, Contraceptive Pills, Spermicides), Contraceptive Devices (Contraceptive Patches, Contraceptive Sponges, Diaphragms & Caps), Distribution Channel - Forecast 2024-2030 - Product Image

Global Female Contraceptive Market by Contraceptive Drug (Contraceptive Injections, Contraceptive Pills, Spermicides), Contraceptive Devices (Contraceptive Patches, Contraceptive Sponges, Diaphragms & Caps), Distribution Channel - Forecast 2024-2030

  • Report
  • 183 Pages
  • Global
From
Global Oral Contraceptive Pills Market by Type (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Category, Distribution - Forecast 2024-2030 - Product Image

Global Oral Contraceptive Pills Market by Type (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Category, Distribution - Forecast 2024-2030

  • Report
  • 193 Pages
  • Global
From
Contraceptive Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Contraceptive Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 141 Pages
  • Global
From
Global Contraceptive Pills Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Contraceptive Pills Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 190 Pages
  • Global
From

About the Contraception Market

The Contraception market within the context of Personal Care Products is a large and diverse industry. It includes a wide range of products, from condoms and diaphragms to hormonal contraceptives such as the pill and intrauterine devices. Contraception is used to prevent pregnancy and is an important part of sexual health. It is also used to treat certain medical conditions, such as endometriosis. Contraception is widely available in pharmacies, supermarkets, and online. The market for contraception is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Church & Dwight, Bayer, Merck, Pfizer, and Allergan. Other companies include Cipla, Mylan, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.